Coccidioidomycosis cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]:Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Given the morbidity and mortality associated with coccidioidomycosis infection, and the low cost of safe and effective antifungals, current pharmacotherapy to treat coccidioidomycosis is relatively cost-effective.^[1]

References

↑ Stockamp NW, Thompson GR (2016). “Coccidioidomycosis”. Infect. Dis. Clin. North Am. 30 (1): 229–46. doi:10.1016/j.idc.2015.10.008. PMID 26739609.

Template:WH Template:WS

[pmid26739609-1] Stockamp NW, Thompson GR (2016). “Coccidioidomycosis”. Infect. Dis. Clin. North Am. 30 (1): 229–46. doi:10.1016/j.idc.2015.10.008. PMID 26739609.

[1]